Document is current
Any future updates will be listed below
-
Authors
Harrison, Thomas E https://orcid.org/0000-0003-1579-8484
Alam, Nawsad
Farrell, Brendan https://orcid.org/0000-0001-9919-9141
Quinkert, Doris https://orcid.org/0000-0003-4135-6452
Lias, Amelia M https://orcid.org/0000-0003-2939-7761
King, Lloyd D W
Barfod, Lea K https://orcid.org/0000-0001-6510-495X
Draper, Simon J https://orcid.org/0000-0002-9415-1357
Campeotto, Ivan https://orcid.org/0000-0002-0814-619X
Higgins, Matthew K https://orcid.org/0000-0002-2870-1955
-
Funding
Funding for this research was provided by:
Wellcome Trust (220797/Z/20/Z)
Wellcome Trust (101020/Z/13/Z)
United States Agency for International Development (7200AA20C00017)
- License Information
-
More Information
Article History
Received: 25 March 2024
Revised: 20 August 2024
Accepted: 20 August 2024
First Online: 2 September 2024
Disclosure and competing interests statement
: MKH, TEH, NA, DQ, AML, LDWK, SJD and IC are inventors of patents related to vaccines and/or monoclonal antibodies which target PfRH5. SJD is a co-founder of and shareholder in SpyBiotech.
